9-FLUORO-16.BETA.-METHYL-3,11,20-TRIOXO-21-(PROPANOYLOXY)PREGNA-1,4-DIEN-17-YL BUTANOATE
UNII 3CYB3Z4ENV
Substance Identification & Data
This profile provides standardized clinical and technical data for 9-fluoro-16.beta.-methyl-3,11,20-trioxo-21-(propanoyloxy)pregna-1,4-dien-17-yl Butanoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3CYB3Z4ENV.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C29H37FO7 MLDJMNDYDGECOM-NWHKNGBNSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 9-fluoro-16.beta.-methyl-3,11,20-trioxo-21-(propanoyloxy)pregna-1,4-dien-17-yl Butanoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.